Boc-Arg(Boc)2-OH

Boc-Arg(Boc)2-OH is a protected arginine building block featuring a Boc-protected alpha-amino group and a Boc-protected guanidinium side chain, supplied as a protected amino acid derivative for peptide assembly. The presence of the strongly basic guanidinium functionality, masked as a Boc-protected group, supports controlled incorporation of arginine residues into protected peptide segments while minimizing undesired side reactions during chain elongation. This reagent is commonly used in peptide synthesis workflows where orthogonal protection and reliable deprotection strategies are required to generate arginine-containing peptides and related pharmaceutical intermediates.

1. Fmoc-Compatible Peptide Segments

Boc-Arg(Boc)2-OH is used by custom peptide synthesis groups and medicinal chemistry laboratories to incorporate arginine residues into protected peptide segments when Boc-based protection schemes are employed. The Boc-protected guanidinium side chain helps maintain the strongly basic character of arginine in a masked form during coupling and intermediate handling, which is particularly valuable for building longer sequences containing multiple basic residues. Downstream, controlled deprotection allows access to the native guanidinium functionality in the assembled peptide, supporting the preparation of arginine-rich peptides used in structure-activity relationship studies and peptide lead optimization.

2. Boc/Boc Peptide Library Synthesis

Boc-Arg(Boc)2-OH supports peptide library construction where consistent protection of both the alpha-amino group and the arginine side chain is required to streamline parallel synthesis and purification. Research teams developing combinatorial peptide sets often rely on Boc-protected arginine derivatives to reduce variability associated with side-chain reactivity and to standardize handling across different analogs. This makes the reagent a practical choice for generating peptide intermediates that preserve the arginine side chain as a protected group until the final deprotection step, enabling efficient downstream screening workflows in chemical biology and medicinal chemistry programs.

3. Pharmaceutical Intermediate Assembly

Boc-Arg(Boc)2-OH is widely used in pharmaceutical intermediate development for preparing arginine-containing protected fragments that serve as building blocks toward larger drug-like molecules, peptidomimetics, and peptide-based candidates. The masked guanidinium group is advantageous during multi-step synthesis because it reduces the likelihood of salt formation and side reactions that can complicate purification and coupling in intermediate stages. Synthetic teams value this protected arginine derivative for producing well-defined intermediates that can be carried forward into final assembly steps where deprotection and conversion to the active structural motif are performed under controlled conditions.

4. Arginine-Rich Peptide Standards

Boc-Arg(Boc)2-OH is used to generate protected or partially deprotected arginine-containing peptide standards for analytical method development and characterization workflows. Analytical laboratories preparing reference materials for LC-MS, HPLC, and peptide mapping commonly require reproducible arginine-containing sequences and fragments, especially when basic residues influence retention behavior and ionization. By using a Boc-protected arginine building block, researchers can build defined peptide fragments with the arginine side chain protected during synthesis and handling, improving consistency from batch to batch and supporting reliable characterization of peptide products and intermediates.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. High fat diet and GLP-1 drugs induce pancreatic injury in mice